During dose escalation when GI side effects peak, increase your baseline by 20-30%
It makes the body release more insulin after meals and produce less glucagon, helping control blood sugar levels
Never double-dose
September 1, 2024: Kentucky Woman Files Lawsuit Alleging Ozempic Caused Gastroparesis On August 27, 2024, a 43-year-old Kentucky woman filed an Ozempic lawsuit, alleging that the GLP-1 drugs caused her gastroparesis, or stomach paralysis
Up to 40% of weight lost on these medications may be muscle, which can weaken the body, slow metabolism, and impair function
Why It Matters The findings come as usage of weight-loss jabs surges in the United States a Rand Corporation survey from last August found that nearly 12 percent of Americans had used glucagon-like peptide (GLP-1) drugs, including Wegovy and Mounjaro, for weight loss